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Abstract
Recent advances in RNA sequencing (RNA-Seq) have enabled the discovery of novel transcriptomic
variations that are not possible with traditional microarray-based methods. Tissue and cell specific
transcriptome changes during pathophysiological stress in disease cases versus controls and in response to
therapies are of particular interest to investigators studying cardiometabolic diseases. Thus, knowledge on the
relationships between sequencing depth and detection of transcriptomic variation is needed for designing
RNA-Seq experiments and for interpreting results of analyses. Using deeply sequenced Illumina HiSeq 2000
101 bp paired-end RNA-Seq data derived from adipose of a healthy individual before and after systemic
administration of endotoxin (LPS), we investigated the sequencing depths needed for studies of gene
expression and alternative splicing (AS). In order to detect expressed genes and AS events, we found that
∼100 to 150 million (M) filtered reads were needed. However, the requirement on sequencing depth for the
detection of LPS modulated differential expression (DE) and differential alternative splicing (DAS) was much
higher. To detect 80% of events, ∼300 M filtered reads were needed for DE analysis whereas at least 400 M
filtered reads were necessary for detecting DAS. Although the majority of expressed genes and AS events can
be detected with modest sequencing depths (∼100 M filtered reads), the estimated gene expression levels and
exon/intron inclusion levels were less accurate. We report the first study that evaluates the relationship
between RNA-Seq depth and the ability to detect DE and DAS in human adipose. Our results suggest that a
much higher sequencing depth is needed to reliably identify DAS events than for DE genes.
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Recent advances in RNA sequencing (RNA-Seq) have enabled the discovery of novel transcriptomic variations that are not
possible with traditional microarray-based methods. Tissue and cell specific transcriptome changes during pathophysi-
ological stress in disease cases versus controls and in response to therapies are of particular interest to investigators
studying cardiometabolic diseases. Thus, knowledge on the relationships between sequencing depth and detection of
transcriptomic variation is needed for designing RNA-Seq experiments and for interpreting results of analyses. Using deeply
sequenced Illumina HiSeq 2000 101 bp paired-end RNA-Seq data derived from adipose of a healthy individual before and
after systemic administration of endotoxin (LPS), we investigated the sequencing depths needed for studies of gene
expression and alternative splicing (AS). In order to detect expressed genes and AS events, we found that ,100 to 150
million (M) filtered reads were needed. However, the requirement on sequencing depth for the detection of LPS modulated
differential expression (DE) and differential alternative splicing (DAS) was much higher. To detect 80% of events, ,300 M
filtered reads were needed for DE analysis whereas at least 400 M filtered reads were necessary for detecting DAS. Although
the majority of expressed genes and AS events can be detected with modest sequencing depths (,100 M filtered reads),
the estimated gene expression levels and exon/intron inclusion levels were less accurate. We report the first study that
evaluates the relationship between RNA-Seq depth and the ability to detect DE and DAS in human adipose. Our results
suggest that a much higher sequencing depth is needed to reliably identify DAS events than for DE genes.
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Introduction
A transcriptome represents a collection of all transcribed
sequences present in a given cell. Unlike a genome, which is
roughly fixed, the composition of the transcriptome can be quickly
restructured by changing the rate of synthesis or decay of
individual mRNAs in response to external environmental condi-
tions. The characterization of gene expression in cells has long
been of interest to researchers because alterations in transcriptome
profiles in response to specific biological stimuli provides valuable
insights for interpreting functional elements of the genome and
understanding disease pathogenesis. Tissue and cell specific
transcriptomic changes during stress, in disease versus health
and in response to therapies are of particular interest to
investigators studying cardiometabolic diseases.
In the past decade, microarrays have been the method of choice
for transcriptomics studies due to their ability to measure
thousands of transcripts simultaneously [1]. However, microarrays
are subject to biases in hybridization strength, and potential for
cross-hybridization to probes with similar sequences [2]. Addi-
tionally, microarrays are unable to identify novel genes and
splicing events because of their reliance on existing gene models.
RNA sequencing (RNA-Seq) is an emerging approach for
transcriptome profiling that allows an unbiased survey of the
entire transcriptome in a high-throughput manner [3]. With deep
coverage and single nucleotide resolution, RNA-Seq provides a
platform to determine differential expression of genes or isoforms
[4], alternative splicing (AS) [5], non-coding RNAs [6], post-
transcriptional modifications [7,8], and gene fusions [9].
Although RNA-Seq has revolutionized transcriptomics studies,
the expense of sequencing is still a major limiting factor to
obtaining highly informative datasets. Thus, knowledge of the
relationships between sequencing depth and transcriptomic
variation detection is critical for proper design of RNA-Seq
experiments and for understanding the characteristics of the
results. Sequencing depth represents the total number of
sequenced reads, which can be increased by using more lanes.
Despite its importance, empirical assessment of the impact of
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sequencing depth on transcriptome profiling is limited. A few
studies have examined the relationship between sequencing depth
and the detection of expressed genes and isoforms [10,11,12].
However, results from these studies cannot be extrapolated to
questions that are beyond the detection of static gene or isoform
expression. In many cardiovascular studies, it is often of interest to
compare transcriptomic profiles between different physiological
conditions, disease states and drug therapies. Therefore, it is
imperative to investigate the effect of sequencing depth on
detection of transcriptomic changes in order to properly design
and interpret these types of experiments in disease relevant tissues.
By utilizing deeply sequenced RNA-Seq samples obtained from
adipose of a single healthy individual before and after systemic
administration of endotoxin (LPS), we set out to evaluate the effect
that sequencing depth has on the statistical analysis of RNA-Seq
data in an evoked model of innate immune stress of direct
relevance to cardiometabolic disease [13,14,15,16]. Specifically,
we evaluated how sequencing depth relates to the identification of
expressed genes and AS as well as to the detection of LPS-
modulated differential gene expression and differential AS.
Findings from our investigation provide a practical guide for
researchers when designing RNA-Seq experiments in cells and
tissues of direct relevance to cardiometabolic disease.
Materials and Methods
Study Subject
The subject is a healthy Caucasian female individual selected
from the Genetics of Evoked responses to Niacin and Endotox-
emia (GENE) study (n= 294), a recently completed National
Institute of Health-sponsored experimental endotoxemia protocol
performed at the University of Pennsylvania (UPenn) [17]. The
GENE study was performed with the approval of UPenn’s
Institutional Review Board after written informed consent was
obtained from all research participants. All subjects underwent an
inpatient endotoxemia protocol lasting approximately 40 hours,
including a pre-LPS acclimatization phase, administration of IV
LPS bolus (1 ng/Kg), and a 30-hour post-LPS phase. As described
earlier [16,18], samples of gluteal subcutaneous fat tissue were
obtained at baseline, 4, 12 and 24 hours following LPS using a
liposuction catheter under local anesthesia and snap-frozen for
subsequent RNA extraction. Based on prior microarray mRNA
profiling in independent samples [18], we selected baseline and 4-
hr adipose samples for RNA-Seq.
RNA-Seq Library Preparation and Sequencing
The RNA was extracted using RNeasy Lipid Tissue total RNA
mini kit (Qiagen, Valencia, CA), underwent quality control using
the Agilent Bioanalyzer (Agilent, Santa Clara, CA). Poly-A library
preparation and sequencing were performed at the Penn Genome
Frontiers Institute’s High-Throughput Sequencing Facility using
Illumina’s HiSeq 2000 with four lanes per sample which generated
26101 bp paired-end reads. Technical replicate data from the
same individual were generated from independent library
preparations and sequenced using two samples per lane.
Poly-A library preparation and sequencing were performed at
the Penn Genome Frontiers Institute’s High-Throughput Se-
quencing Facility per standard protocols. Briefly, we generated
first-strand cDNA using random hexamer-primed reverse tran-
scription, followed by secondstrand cDNA synthesis using RNase
H and DNA polymerase, and ligation of sequencing adapters
using the TruSeq RNA Sample Preparation Kit (Illumina, San
Diego, CA). Fragments of ,350 bp were selected by gel
electrophoresis, followed by 15 cycles of PCR amplification. The
prepared libraries were then sequenced using Illumina’s HiSeq
2000 with four lanes per sample which generated 26101 bp
paired-end reads. Technical replicate RNA-Seq data from the
same individual were generated from independent library
preparations and sequenced using two samples per lane.
Alignment of RNA-Seq Reads
The RNA-Seq data were aligned to the hg19 reference genome
using Tophat v1.3.3 with default options [19]. In order to
eliminate mapping errors and reduce potential mapping ambiguity
due to homologous sequences, several filtering steps were applied.
Specifically, we required the mapping quality score of each read to
be $30, reads from the same pair were mapped to the same
chromosome with expected orientations and the mapping distance
between the read pair was ,500,000 bp, and each read was
uniquely mapped to the genome. All subsequent analyses were
based on filtered alignment files.
Random Sampling of Aligned RNA-Seq Reads
To investigate the effect of sequencing depth on analysis of
RNA-Seq data, after removing reads mapped to the mitochondrial
genome (based on Tophat alignment), we randomly selected reads
from the filtered alignment files (482 million (M) reads for pre-
LPS; 519 M reads for post-LPS) and created subsets with 5 M,
10 M, 15 M, 20 M, 25 M, 50 M, 75 M, 100 M, 150 M, 200 M,
300 M, 400 M reads for both the pre- and post-LPS samples.
For empirical validations, we used technical replicate RNA-Seq
data generated from independent library preparations using two
samples per lane which resulted in 67 M and 65 M reads for the
pre- and post-LPS samples, respectively, with 36 M reads and
33 M reads after filtering and removal of reads mapping to the
mitochondrial genome.
Analysis of Gene Expression
Transcripts were assembled and gene expression levels were
estimated using Cufflinks v1.3.0 [4]. A gene was declared as
expressed if the FPKM (Fragments Per Kilobase of exon per
Million fragments mapped) value was .0. For each gene, we
compared the gene expression levels between pre- and post-LPS
administration using the cuffdiff option in Cufflinks. A gene was
declared as differentially expressed if the FDR adjusted p-value
was #0.05.
Analysis of Alternative Splicing
To identify alternative splicing (AS) events, we used MATS
[20], a computational tool that detects differential AS events from
RNA-Seq data. We favored MATS over other tools (e.g., MISO
[21] and DiffSplice [22]) because of our experimental design and
the ease of use and robustness of the program. MATS tests that the
difference in the exon or intron inclusion level of a gene (defined
by refSeq in our analysis) between two conditions exceeds a user-
defined threshold (0.05 in our analysis). From RNA-Seq data,
MATS can automatically detect AS events corresponding to all
major types of AS, including exon skipping, mutually exclusive
exons, alternative 59 splice site, alternative 39 splice site, and intron
retention. An AS event was declared if the inclusion level of an
exon or an intron was between 0 and 1. A differential AS event
was declared if the FDR adjusted p-value was #0.05.
Results
Clinical Characteristics of the Study Subject
Clinical and biochemical responses to LPS in all European
Ancestry participants in the GENE study as well as for the study
Impact of Sequencing Depth in RNA-Seq Studies
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subject are shown in Table S1. Compared to GENE participants,
the selected study subject had similar baseline characteristics with
normal blood pressure, blood glucose, and plasma lipoproteins.
We selected this subject due to their high biochemical inflamma-
tory response (84 percentile peak IL-6, 64 percentile peak TNFa,
and 87 percentile peak temperature in the 24 hours post-LPS)
(Table S1), supporting a robust modulation of the transcriptome.
RNA-Seq Data Alignment
We obtained 912 million (M) and 1,040 M reads for the pre-
and post-LPS samples, respectively, with a high mapping rate,
85% and 82% of the reads mapped to the reference genome for
the pre- and post-LPS samples, respectively, and 72% and 69% of
the reads uniquely mapped and properly filtered (Table 1). In our
analysis, we only considered reads from autosomal and sex
chromosomes, and this left 482 M filtered reads pre-LPS and
519 M filtered reads post-LPS. For ease of notation, we denote the
482 M and 519 M filtered datasets both as 500 M, and assume
results from the analyses of these two datasets provide a
comprehensive catalogue of transcriptomic variation.
Impact of Sequencing Depth on Analysis of Gene
Expression
Detection of gene expression. To assess the relationship
between sequencing depth and gene expression, we divided our
500 M datasets into smaller subsets randomly and analyzed how
the detection of a gene varies with sequencing depth. For the pre-
LPS sample, we found that with 5 M reads, only 16% of the
expressed genes were detected. The detection rate quickly
increased to 79% when the sequencing depth increased to
100 M (Figure 1(A); Table S2). After the sequencing depth
reached 150 M, the percentage of additionally detected genes
became less pronounced and each additional 100 M reads only
offered 3% to 5% more genes, suggesting that the improvement of
sequencing depth after 150 M had relatively less impact on
detecting low abundance genes. We observed an almost identical
pattern for the detection rate for the post-LPS sample, although
the numbers of detected genes were different from the pre-LPS
sample (Table S2).
Detection of differential gene expression. Because detec-
tion of differentially expressed (DE) genes is a key focus for many
cardiometabolic studies, we investigated the sequencing depth
needed to identify LPS-modulated genes. The pattern for detected
pre- and post-LPS DE genes was different from expressed genes.
Only a small number of the DE genes were detected at low depths;
for the 5 M-read dataset, less than 2% of the DE genes were
detected, in contrast to 16% for the expressed genes detected at
the same sequencing depth. The detection rate was increased to
45% when the sequencing depth increased to 100 M. Unlike
expressed genes, which reached a plateau, for DE genes, the
detection rate increased steadily as sequencing depth increased,
and in order to detect 80% of the DE genes, 300 M reads were
necessary (Figure 1(A); Table S2). We note that the curves for
pre-LPS and post-LPS samples are overlapping, although the
numbers of detected genes were different (Table S2). Our results
suggest that although expressed genes can be detected at relatively
low sequencing depth, the accuracy of the estimated gene
expression levels may not be sufficient to determine modest gene
expression changes modulated by LPS or in other experimental or
disease settings.
Correlations of gene expression and differential gene
expression across datasets. We next evaluated how accurate
the estimated FPKM values and the corresponding fold change of
the FPKMs were in all sub-datasets as compared to those obtained
from the 500 M-read datasets. For each subset, we calculated the
Spearman correlations of the FPKM values with the 500 M-read
datasets for both the pre- and post-LPS samples. The spearman
correlations were relatively high even for low sequencing depths
(Figure 1(B)); for the 5 M-read datasets, the correlations with the
500 M-read dataset were 0.88 and 0.74, for the pre- and post-LPS
samples, respectively. The correlations were above 0.9 for both
pre-LPS and post-LPS samples when the read depths increased to
100 M (Figure 1(B); Figures S1–S3). At the same sequencing
depth, the correlation for fold-change in gene expression (post-LPS
vs. pre-LPS) was always smaller than the corresponding correla-
tions for the FPKM values, and the degree of discrepancy was
more pronounced at lower sequencing depth (Figure 1(B)). For
example, with 10 M reads, the correlations for the pre-LPS and
post-LPS FPKM values were 0.88 and 0.75, respectively, whereas
the correlation for the fold change of gene expression was only
0.63. This suggests that at lower sequencing depth, one would not
only miss a large portion of the DE genes, but would also suffer
from a less accurate estimation of the magnitude of gene
expression changes.
Impact of gene expression levels. Despite overall good
correlations between replicates, in one of the first large RNA-Seq
studies with technical replicates, Mortazavi et al. [23] observed
reduced precision for lower expressed transcripts. In order to
assess the impact of gene expression levels on our results, we
looked at highly-expressed genes and lowly-expressed genes
separately based on their FPKM values in the 500 M-read
datasets. ‘‘Highly-expressed genes’’ were defined as those with
FPKM values .75th percentile for both the pre-LPS (75th
percentile FPKM=11.46) and post-LPS (75th percentile
FPKM=9.09) samples, and ‘‘lowly-expressed genes’’ were defined
as those with the FPKM values ,25th percentile (25th percentile
FPKM=1.51 pre-LPS, 0.85 post-LPS).
Table 1. Mapping statistics.
Sample Time Reads Reads mapped (%) Reads after filtering (%)
Autosomal and sex chromosome
reads after filtering (%)
Original Pre-LPS 911,584,508 771,290,702 (85%) 655,529,906 (72%) 481,769,060 (53%)
Post-LPS 1,039,937,222 856,379,122 (82%) 718,792,994 (69%) 518,576,050 (50%)
Technical
replicate
Pre-LPS 66,603,980 57,113,510 (86%) 49,217,950 (74%) 36,253,892 (54%)
Post-LPS 64,824,708 53,726,630 (83%) 45,005,478 (69%) 32,587,354 (50%)
Data were aligned to the hg19 reference genome using Tophat v1.3.3.
doi:10.1371/journal.pone.0066883.t001
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As expected, the expression level affects how readily a gene was
detected. Figure 1(C) shows that the detection rate for lowly-
expressed genes was significantly lower than that for highly-
expressed genes. For highly-expressed genes, 10 M reads could
detect 80% (pre-LPS) and 73% (post-LPS) of the genes that were
expressed. With the same number of reads, less than 2% of the
lowly-expressed genes were detected for both the pre- and post-
LPS samples. The gene expression also affected the detection of
DE genes. For example, with 100 M reads, among highly-
expressed genes, 38% of the DE genes were detected as compared
to 20% DE genes detected among lowly-expressed ones
(Figure 1(C); Table S3). The discrepancy became more
pronounced as sequencing depths decreased; with read depths
,75 M, none of the DE genes among those lowly-expressed genes
were detected, whereas about one third of the DE genes among
highly-expressed ones were detected at 75 M. Our results
confirmed that read depths have a much larger impact on the
detection of expression and especially DE for low abundance
genes.
Sensitivity and specificity. We also characterized the
sensitivity and specificity for DE genes at various sequencing
depths. This is an important question because some DE genes
detected in datasets with lower sequencing depths were not
detected in the 500 M-read datasets, suggesting false positives.
Assuming the 500 M-read datasets as the gold standard, we
classified DE genes detected in datasets with lower sequencing
depths into four categories. A gene was classified as ‘‘false positive’’
(FP) if it was detected in a subset but not in the 500 M datasets; a
gene was classified as ‘‘false negative’’ (FN) if it was missed in a
subset but detected as DE in the 500 M-read datasets. Similarly,
we defined ‘‘true positive’’ (TP) and ‘‘true negative’’ (TN) genes.
Based on these definitions, we calculated the numbers of genes in
each category, and this allowed us to estimate the sensitivity (i.e.,
TP/(TP+FN)), specificity (i.e., TN/(FP+TN)), and false discovery
rate (FDR) (i.e., FP/(FP+TP)) for DE genes detected at each
sequencing depth. As shown in Figure 1(D) (and Table S4),
overall the specificity was high e.g., 97% even when the
sequencing depth was as low as 5 M. However, the sensitivity
was strongly dependent on the sequencing depths; with 10 M
reads, the sensitivity was only 16%. To achieve 80% sensitivity,
300 M reads were necessary. The FDR was close to 40% with
Figure 1. Analysis results for differentially expressed (DE) genes in adipose. (A) Percentage of detected expressed genes and
differentially expressed (DE) genes for datasets with various sequencing depths. PreLPS: detection rate for expressed genes in the pre-LPS
sample; post-PLS: detection rate for expressed genes in the post-LPS sample; DE: detection rate for DE genes. The curves for pre-LPS and post-LPS
samples overlap, although the numbers of detected genes were different (Table S1). (B) Spearman correlation between FPKM values in
datasets with various sequencing depths and FPKM values in the 500 M-read datasets. PreLPS: correlation of FPKM values in the pre-LPS
sample; postLPS: correlation of FPKM values in the post-LPS sample; fold-change: correlation of the fold change of FPKM values. (C) Percentage of
detected DE genes according to gene expression levels. PreLPS_high: detection rate for gene expression in highly expressed genes in the pre-
LPS sample; preLPS_low: detection rate for gene expression in lowly expressed genes in the pre-LPS sample; postLPS_high: detection rate for gene
expression in highly expressed genes in the post-LPS sample; postLPS_low: detection rate for gene expression in lowly expressed genes in the post-
LPS sample; DE_high: detection rate for DE genes in highly expressed genes; DE_low: detection rate for DE genes in lowly expressed genes. (D)
Performance of DE genes detected in datasets with various sequencing depths.
doi:10.1371/journal.pone.0066883.g001
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5 M reads but fell quickly when the sequencing depth increased
e.g., to 12% at 100 M reads and to 5% at 300 M reads.
Impact of Sequencing Depth on Analysis of Alternative
Splicing
Detection of AS. An exciting feature of RNA-Seq lies in its
ability to study AS, a regulated process during gene expression in
which particular exons of a gene may be included or excluded
from the final processed mRNAs. In humans, it is estimated that
more than 90% of the multiexonic genes are alternatively spliced
[5]. An exon was declared to have undergone AS if the exon
inclusion level was between zero and one. This type of AS is
defined as exon skipping, which is the most common type of AS
[5]. Similar inclusion levels were calculated for other types of AS
in MATS [20] including mutually exclusive exons, alternative 59
splice site, alternative 39 splice site, and intron retention. Since the
patterns were consistent across all types of AS events, in our
analysis, we considered all AS events together. The patterns of
detected AS events were broadly similar to that for expressed
genes. AS events could be detected at low sequencing depths e.g.,
for the pre-LPS sample, 30% of the AS events were detected with
10 M reads and the detection rate quickly reached to 83% when
the read depth increased to 150 M (Figure 2(A); Table S5).
Detection of differential AS. Next, we investigated the
sequencing depth needed to study differential AS (DAS) events.
Strikingly, none of the DAS events were detected in datasets with
sequencing depth below 50 M reads, and only 9% of the DAS
events were detected with 100 M reads, in sharp contrast to 76%
detection rates for AS events at this depth. In order to detect
,80% of the DAS events, at least 400 M reads were needed.
Since the curve for detection rate did not hit a plateau
(Figure 2(A), this suggests that even at higher sequencing depths
many DAS events are difficult to identify with current RNA-Seq
protocols.
Correlations of AS and DAS across datasets. In the
analysis of AS, it is important to quantify exon/intron inclusion
level as it reflects the relative abundance of different isoforms. For
AS and DAS events detected in datasets with various sequencing
depths, we calculated the Spearman correlations of the inclusion
levels and fold-change in inclusion levels with that in the 500 M-
read datasets. As expected, the spearman correlations for inclusion
levels were relatively high even at low sequencing depths
(Figure 2(B); Figures S4–S6); for the 5 M-read datasets, the
correlations were 0.69 and 0.74 for the pre- and post-LPS samples,
respectively, and quickly reached to 0.9 when the sequencing
depths increased to 75 M. At the same sequencing depth, the
correlation for fold change of inclusion level was always smaller
than the corresponding correlations for the inclusion levels, and
further, it was smaller than the fold change for the corresponding
gene expression results. For example, with 10 M reads, the
correlation for fold change of gene expression was 0.63, whereas
the correlation for fold change of inclusion level was only 0.54.
This reduced correlation is likely because in datasets with lower
sequencing depths, the numbers of junction reads are small which
result in more variability in the estimation of inclusion levels.
Impact of gene expression levels. The gene expression
levels are likely to have an impact on the AS analysis because
lowly-expressed genes generally have less junction reads, which are
crucial for the analysis of AS. We considered the impact of highly-
expressed genes and lowly-expressed genes separately
(Figure 2(C)). As expected, we detected more AS and DAS
events for highly-expressed genes than for lowly-expressed genes
(Table S6). At the same sequencing depth, about three time more
AS events were detected for highly-expressed genes than for lowly-
expressed genes. A similar pattern was observed for the detection
of DAS. Sensitivity and Specificity. Next, we estimated the
sensitivity, specificity, FDR, and accuracy for the detected DAS
events at various sequencing depths. We calculated the numbers of
‘‘false positive’’, ‘‘false negative’’, ‘‘true positive’’, and ‘‘true
negative’’ DAS events by treating results from the 500 M-read
datasets as the gold standard. As shown in Figure 2(D) (Table
S7), the specificity was high across all sequencing depths but the
sensitivity was low when sequencing depth was less than 200 M
reads. In order to get non-zero sensitivity, 50 M reads were
necessary and even with 200 M reads, the sensitivity was only
around 30%. Overall in order to achieve 80% sensitivity, at least
400 M reads were needed. The overall FDR was low; however,
FDR should be interpreted with caution because the low FDR as
well as the noticeable increase at 25 M were driven by the small
number of detected DAS events when sequencing depths were low
(Table S7).
Impact of Sampling Variations
In our primary analysis, we sampled once for each sequencing
depth when creating subsets with various numbers of reads. This
sampling scheme reflects what happens in real studies because
most investigators can only afford to sequence a sample once.
However, in experiments with low sequencing depth, it is crucial
to evaluate whether the sequenced reads are representative. To
evaluate sampling variations, we randomly sampled 100 M reads
and 10 M reads from the 500 M-read datasets 10 times for both
the pre- and post-LPS samples, and repeated our analyses for gene
expression and AS. We observed high correlations for the FPKM
values and the fold change of the FPKMs among the 10 samplings
(Figure 3(A)). As expected, the sampling variation was smaller for
the 100 M-read datasets than for the 10 M-read datasets.
However, the corresponding correlations for the exon/intron
inclusion levels (AS) and the fold change of inclusion levels (DAS)
were lower (Figure 3(B)), especially when the sequencing depth
was as low as 10 M reads. This result suggests that sampling
variations has little effect on the analysis of gene expression, but its
impact on the analysis of AS is substantial.
Until now, our analyses have been restricted to randomly
sampled sequence reads from data generated in a single
sequencing run. These selected reads may have less variation
than data obtained from different sequencing runs. In order to
evaluate this further, we analyzed technical replicate RNA-Seq
data generated from the same study subject, where the numbers of
reads after filtering were 36 M and 33 M for pre-LPS and post-
LPS, respectively (Table 1). Based on these data, we examined
the numbers of expressed and DE genes, and AS and DAS events
and compared these findings to those from data subsets sampled at
36 M and 33 M reads from the 500 M-read datasets. Table 2
shows that the results are broadly similar, confirming that results
obtained from resampled data are representative of empiric data;
however, the low overlap in DAS events underscores the lack of
sensitivity of low sequence depth for DAS analysis.
Discussion
Tissue and cell-specific transcriptomic modulation in disease
and during experimental interventions are an emerging interest in
the study of cardiometabolic diseases [24]. In this study, using
deeply sequenced RNA-Seq data derived from adipose of a
healthy individual before and after systemic administration of LPS,
we investigated the sequencing depths needed for studies of
various types of transcriptomic variations. In particular, we
examined what sequencing depths were needed for studying gene
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expression and AS. We found that to detect expressed genes,
,100 M reads (after filtering and removal of mitochondrial reads)
were needed. However, in order to detect DE genes, the
requirement on sequencing depth was much higher. In general,
,300 M reads were needed to detect 80% of the identified DE
genes. We also investigated the sequencing depth needed for the
analysis of AS. To detect AS events, ,150 M reads were
necessary; however, to detect DAS events, a much higher
sequencing depth was needed; at least 400 M reads were necessary
to achieve an 80% detection rate. These findings provide a
practical guide and cautionary note for researchers when
designing RNA-Seq experiments in cells and tissues of direct
relevance to cardiometabolic disease.
The sequencing depth needed for a given study depends on
several factors including genome size, transcriptome complexity
and objectives of the study. Depending on the purpose of the
analysis, the requirement of sequencing depth varies. In most
transcriptomics studies, quantifying gene expression is the major
objective. As shown by several groups [10,11,12] and confirmed
by us, there is a certain sequencing depth that is sufficient for
detection of expressed genes, implying that increasing sequencing
depth after reaching a certain threshold has little impact on gene
detection. For example, our data suggest that after the sequencing
depth reached 150 M filtered reads, the percentage of additionally
detected genes became less pronounced. This indicates that
,300 M raw sequence reads were needed, equivalent to 1.5 lanes
per sample if sequencing is performed using Illumina’s HiSeq
2000. However, our analysis demonstrates for the first time that
reliable detection of DE genes, at least in adipose, requires much
deeper sequencing than has been applied typically. Further, by
separating genes by expression levels, we observed substantial
difference between highly-expressed genes and lowly-expressed
genes in terms of the detection of expressed genes and DE genes.
Detection of low abundance genes and of DE of such genes was
greatly impacted by sequencing depth. This finding is particularly
relevant to study design when the goal is to detect DE genes that
are novel and of low expression.
A unique strength of RNA-Seq is its capacity to identify AS and
DAS in an unbiased manner. Detection of AS in our adipose
RNA-Seq data had a similar pattern to that for gene expression
except that greater sequencing depth was required to detect AS
events; for example, to achieve 80% detection rate, 100 M filtered
Figure 2. Analysis results for alternative splicing (AS) and differential AS (DAS) in adipose. (A) Percentage of detected alterantive
splicing (AS) and differential AS (DAS) events for datasets with various sequencing depths. PreLPS: detection rate for AS events in the
pre-LPS sample; postLPS: detection rate for AS events in the post-LPS sample; DAS: detection rate for DAS events. (B) Spearman correlation
between exon or intron inclusion levels in datasets with various sequencing depths and inclusion levels in the 500 M-read
datasets. PreLPS: correlation of inclusion levels in the pre-LPS sample; postLPS: correlation of inclusion levels in the post-LPS sample; fold-change:
correlation of the fold change of isoform ratios. (C) Percentage of detected AS and DAS events according to gene expression levels.
preLPS_high: detection rate for AS in highly expressed genes in the pre-LPS sample; preLPS_low: detection rate for AS in lowly expressed genes in the
pre-LPS sample; postLPS_high: detection rate for AS in highly expressed genes in the post-LPS sample; postLPS_low: detection rate for AS in lowly
expressed genes in the post-LPS sample; DAS_high: detection rate for DAS in highly expressed genes; DAS_low: detection rate for DAS in lowly
expressed genes. (D) Performance of DAS events detected in datasets with various sequencing depths.
doi:10.1371/journal.pone.0066883.g002
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Figure 3. Spearman correlation boxplot for randomly simulated datasets. (A) Boxplot of Spearman correlations for FPKM values
and fold change of FPKM values among 10 randomly sampled datasets. For each sequencing depth (10 M or 100 M), the correlation was
calculated for each of the 45 pair-wise comparisons. (B) Boxplot of Spearman correlations for exon/intron inclusion levels and fold change
of inclusion levels among 10 randomly sampled datasets. For each sequencing depth (10 M or 100 M), the correlation was calculated for
each of the 45 pair-wise comparisons.
doi:10.1371/journal.pone.0066883.g003
Table 2. Numbers of expressed genes, differentially expressed (DE) genes, alternative splicing (AS) events and differential AS (DAS)











Technical replicate 15,962 15,324 732 7,506 7,347 12
Resampled data 16,064 15,375 748 8,805 8,586 8
Overlap 15,400 14,756 598 5,562 5,510 1
*67 M and 65 M reads for the pre-LPS and post-LPS samples, respectively, with 36 M reads and 33 M reads after filtering and removal of reads mapped to mitochondria.
doi:10.1371/journal.pone.0066883.t002
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reads were needed for gene expression but 150 M filtered reads
were necessary for AS. In a manner that parallels that for the
impact of gene expression level on the analysis of gene expression,
low number of junction reads (i.e., low expression) greatly
impacted the detection of AS and required much higher
sequencing depth.
Detection of tissue or cell-specific disease or drug-related DAS
may provide novel insight into specific genes and proteins that
modulate cardiometabolic disease and therapeutic responses.
Therefore, it is of great interest to identify DAS under different
disease and experimental conditions. Strikingly, the curves for
DAS detection rate did not reach a plateau suggesting that
increasing sequencing depth even beyond 500 M filtered reads
would provide more reliable detection of DAS in our adipose data.
Since RNA-Seq remains expensive and most investigations cannot
afford to sequence even to 500 M reads, results reported from
most experiments with lower sequencing depth likely represent a
very incomplete picture for DAS. For example, our data suggest
that a sequencing depth of 200 M reads would detect only ,30%
of DAS and even less for those AS events with relatively low
numbers of junctions reads.
The coverage we report here represents the number of reads
after filtering of inappropriate alignment and removal of reads
mapped to the mitochondrial genome. This may vary by
alignment programs and filtering criteria, and thus may vary
from study to study. Further, our reported coverage represents a
lower bound of the required depth since we were stringent in our
filtering. As better algorithms are developed to improve read
mapping, we anticipate that more reads will be used in gene
expression quantification and AS analysis, and thus reduce the
numbers of reads needed to obtain robust analysis results.
Our study has several unique strengths but also limitations. To
our knowledge, this is the first analysis of sequencing depth on
transcriptomic profiling of differential gene expression and DAS in
human adipose. We applied very deep RNA-Seq, paired tissue
sampling, resampling of sequence reads, and empirical technical
replication of RNA-Seq data in our approach. Our analysis was
restricted, however, to a single individual and it is possible that
findings could vary across individuals and with increasing numbers
of individuals studied. Although experimental endotoxemia is not
a disease model or study design typically used in the study of
cardiometabolic disease, several lines of evidence suggest that
controlled activation of innate immunity in healthy humans may
be informative in cardiometabolic disease [14,15]. We and others
have shown that experimental endotoxemia induces insulin
resistance [14] and atherogenic lipoprotein changes [25] while
observational studies show that sepsis and chronic infection
[26,27] induce metabolic derangements resembling those observed
in obesity, type 2 diabetes and atherosclerosis. Furthermore, LPS
activation of TLR-4 signaling has a well established and robust
impact on regulation of gene expression and AS, thus providing a
highly informative model for our analysis of the sequencing depth
required to detect LPS-modulated DE and DAS in humans. While
we acknowledge that our focus was restricted to adipose tissue and
that findings could vary across distinct cells and tissues, we note
that analysis of adipose tissue transcripts has established its utility
in informing our understanding of complex cardiometabolic
disorders [28,29,30]. Finally, we acknowledge that our findings
might be sensitive to methods used in alignment, filtering, and
analyses as well as the assumption that the 500 M-read datasets
represent a gold standard in our analyses.
Our analysis was restricted to a single individual. Although not
typical (i.e., without biological replicates), our results are partic-
ularly relevant to the design of the GENE study and studies that
involve paired samples (e.g., pre vs. post treatment). In the GENE
study, each participant was administrated low-dose LPS, and we
are interested in identifying transcriptomic variations induced by
LPS in each individual. This is important as our clinical
investigations revealed substantial phenotypic variations among
individuals despite their similar baseline characteristics LPS [17].
The typical differential expression/splicing analyses with biological
replicates will miss signals that are present only in a small number
of individuals. We note that the analysis of single individuals is also
relevant to cancer transcriptomics studies when comparing paired
tumor and normal tissues in which the analysis is typically done at
the individual level.
To assess the generalizability of our findings in other tissues, we
also analyzed the deeply sequenced RNA-Seq data obtained from
blood of the same individual. We analyzed the blood RNA-Seq
data using the same pipeline as employed for adipose. The
patterns for gene expression and AS results are broadly similar to
adipose (Figures S7 and S8), suggesting that our conclusions on
required sequencing depths might be generalized to other tissue
types.
In summary, recent development in sequencing technologies
has allowed us to obtain deep coverage of the human
transcriptome at single-base resolution. We report the first study
that evaluates the appropriate sequencing depth for studying
differential gene expression and differential AS in human adipose
using RNA-Seq. Our results show that a much higher sequencing
depth is needed to reliably identify DAS events and even DE genes
compared to that needed to detect gene expression or AS. While
contemporary sequencing depths in RNA-Seq studies of human
diseases may provide novel and important findings, it is likely that
most lack coverage to reliably detect the full spectrum of disease
relevant differential gene expression and AS. The knowledge
generated from this study provides a realistic foundation for
applications of RNA-Seq in the study of tissue and cell-specific
transcriptomic modulation within cardiometabolic disorders.
Accession Numbers
RNA-seq data have been deposited in the Gene Expression
Omnibus (GEO) database (accession number GSE46323).
Supporting Information
Figure S1 FPKM values estimated from datasets with
various sequencing depths for the pre-LPS sample.
Shown are the values of –log10(FPKM +1). X-axis is for the
500 M-read dataset and Y-axis is for datasets of lower sequencing
depths.
(TIF)
Figure S2 FPKM values estimated from datasets with
various sequencing depths for the post-LPS sample.
Shown are the values of –log10(FPKM +1). X-axis is for the
500 M-read dataset and Y-axis is for datasets of lower sequencing
depths.
(TIF)
Figure S3 Fold change of FPKM values estimated from
datasets with various sequencing depths. Shown are the
values of –log10(fold change +0.01). X-axis is for the 500 M-read
dataset and Y-axis is for datasets of lower sequencing depths.
(TIF)
Figure S4 Exon/intron inclusion levels estimated from
datasets with various sequencing depths for the pre-LPS
sample. X-axis is for the 500 M-read dataset and Y-axis is for
datasets of lower sequencing depths.
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(TIF)
Figure S5 Exon/intron inclusion levels estimated from
datasets with various sequencing depths for the post-
LPS sample. X-axis is for the 500 M-read dataset and Y-axis is
for datasets of lower sequencing depths.
(TIF)
Figure S6 Fold change of inclusion levels estimated
from datasets with various sequencing depths. Shown are
the values of –log10(fold change +0.01). X-axis is for the 500 M-
read dataset and Y-axis is for datasets of lower sequencing depths.
(TIF)
Figure S7 Analysis results for differentially expressed
(DE) genes in blood (A) Percentage of detected expressed
genes and differentially expressed (DE) genes for
datasets with various sequencing depths in blood.
PreLPS: detection rate for expressed genes in the pre-LPS sample;
post-PLS: detection rate for expressed genes in the post-LPS
sample; DE: detection rate for DE genes. The curves for pre-LPS
and post-LPS samples overlap, although the numbers of detected
genes were different (Table S1). (B) Spearman correlation
between FPKM values in datasets with various sequenc-
ing depths and FPKM values in the 500 M-read datasets
in blood. PreLPS: correlation of FPKM values in the pre-LPS
sample; postLPS: correlation of FPKM values in the post-LPS
sample; fold-change: correlation of the fold change of FPKM
values. (C) Percentage of detected DE genes according to
gene expression levels in blood. PreLPS_high: detection rate
for gene expression in highly expressed genes in the pre-LPS
sample; preLPS_low: detection rate for gene expression in lowly
expressed genes in the pre-LPS sample; postLPS_high: detection
rate for gene expression in highly expressed genes in the post-LPS
sample; postLPS_low: detection rate for gene expression in lowly
expressed genes in the post-LPS sample; DE_high: detection rate
for DE genes in highly expressed genes; DE_low: detection rate for
DE genes in lowly expressed genes. (D) Performance of DE
genes detected in datasets with various sequencing
depths in blood.
(TIF)
Figure S8 Analysis results for alternative splicing (AS)
and differential AS (DAS) in blood. (A) Percentage of
detected alterantive splicing (AS) and differential AS
(DAS) events for datasets with various sequencing
depths in blood. PreLPS: detection rate for AS events in the
pre-LPS sample; postLPS: detection rate for AS events in the post-
LPS sample; DAS: detection rate for DAS events. (B) Spearman
correlation between exon or intron inclusion levels in
datasets with various sequencing depths and inclusion
levels in the 500 M-read datasets in blood. PreLPS:
correlation of inclusion levels in the pre-LPS sample; postLPS:
correlation of inclusion levels in the post-LPS sample; fold-change:
correlation of the fold change of isoform ratios. (C) Percentage
of detected AS and DAS events according to gene
expression levels in blood. preLPS_high: detection rate for
AS in highly expressed genes in the pre-LPS sample; preLPS_low:
detection rate for AS in lowly expressed genes in the pre-LPS
sample; postLPS_high: detection rate for AS in highly expressed
genes in the post-LPS sample; postLPS_low: detection rate for AS
in lowly expressed genes in the post-LPS sample; DAS_high:
detection rate for DAS in highly expressed genes; DAS_low:
detection rate for DAS in lowly expressed genes. (D) Perfor-
mance of DAS events detected in datasets with various
sequencing depths in blood.
(TIF)
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